We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available here.
Accept

The Impact of Monitoring Techniques on Progression to Chronic Breast Cancer-related Lymphedema

Chirag Shah, MD, April Zambelli-Weiner, Nicole Delgado, Ashley Sier, Robert Bauserman, Jerrod Nelms

This meta‑analysis comparing bioimpedance spectroscopy versus circumferential measurement includes:

  • 50 lymphedema studies and over 67,000 patients studied
  • Investigated BCRL in breast cancer patients
  • Analyzed impact of prospective monitoring and intervention
Download Study Watch Video

Get the latest updates on L‑Dex® research.
Sign-up now!

3-Key Takeaways from Meta-Analysis Comparing Bioimpedance Spectroscopy vs. Circumferential Measurement

81% Lower Rate of Chronic Lymphedema than Circumference Monitoring

81% Lower Rate of Chronic Lymphedema than Circumference Monitoring

This recent meta-analysis confirms that routine monitoring for early detection of lymphedema using ImpediMed’s L-Dex® technology, combined with early intervention, cuts the relative rate of chronic breast cancer-related lymphedema by 81% when compared to circumference monitoring.

Learn More
Statistically Lower Rates of Chronic Lymphedema in High-Risk Patients and Short-Term and Long-Term Follow-up

Statistically Lower Rates of Chronic Lymphedema in High-Risk Patients and Short-Term and Long-Term Follow-up

The benefit is sustained in high-risk subgroups as well as short-term and long-term follow-up. L-Dex monitoring and intervention studies showed a statistically significant reduction in chronic lymphedema in studies with >50% axillary lymph node dissection (ALND), >40% mastectomy, <2 years follow-up, and >2 years follow-up when compared to circumference studies.

Learn More
Statistically Lower Rates of Chronic Lymphedema in High-Risk Patients and Short-Term and Long-Term Follow-up

Statistically Lower Rates of Chronic Lymphedema in High-Risk Patients and Short-Term and Long-Term Follow-up

The benefit is sustained in high-risk subgroups as well as short-term and long-term follow-up. L-Dex monitoring and intervention studies showed a statistically significant reduction in chronic lymphedema in studies with >50% axillary lymph node dissection (ALND), >40% mastectomy, <2 years follow-up, and >2 years follow-up when compared to circumference studies.

Download Study

Test - Trigger - Treat

Reduce the incidence of Chronic Lymphedema in Breast Cancer Patients with early detection protocol Test, Trigger, Treat™.

Contact us to learn more.

Download Guide